Genzyme Aims To File Clolar Label Expansion For Acute Myelogenous Leukemia In Mid-2008
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm projects global sales of clofarabine for blood cancers to peak at $600 million over ten years, CEO Termeer says.